Failure to Inform Resident of Psychotropic Medication Risks and Benefits
Penalty
No penalty information released
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Summary
The facility failed to inform a resident, admitted with a diagnosis of depression, about the risks and benefits associated with the use of Lexapro, an antidepressant medication. A review of the resident's medical record and physician order dated 5/3/25 showed that the resident was receiving Lexapro daily. However, there was no documentation indicating that the risks and benefits of the medication had been discussed with the resident, nor was there a signed consent form for the medication in the record. This was confirmed by the Director of Nursing Services, who acknowledged that the required information had not been reviewed with the resident and that no signed consent was present.